Can anyone translate [Gregory Geba’s statement] for me?
It’s a longwinded way of complaining that the FDA’s recent reorganization reduced the role of the OGD director by offloading some functions into the new Office of Pharmaceutical Quality (http://www.bna.com/fdas-drug-center-n17179872570/ ).
Market Data 
Markets 
AI
